Key Insights

Highlights

Treatment Research

3 treatments under study, led by Metformin Hydrochloride

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Metformin Hydrochloride1
  • Platelet Rich Fibrin1
  • Alendronate Sodium1

Active Sponsors

  • Bahria University1
  • Islamabad Medical and Dental College1

Top Investigators

Activity Timeline